ACTRN12622000703707
尚未招募
4 期
Personalisation of anti-obesity medication selection based on Eating Behaviour Traits: examining the effect of the novel Auckland Eating Behaviour Questionnaire on weight loss in patients with obesity and type 2 diabetes
概览
- 阶段
- 4 期
- 干预措施
- 未指定
- 疾病 / 适应症
- 未指定
- 发起方
- Auckland District Health Board
- 入组人数
- 175
- 状态
- 尚未招募
- 最后更新
- 3年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •Participants, 18 \- 75 years of age, male and female, who have obesity, WHO class 1 and above (BMI 30\- 50 kg/m2\) will be invited to take part. Participants will need to be willing and able to give informed consent for participation in the study and benefit from weight loss. Only those with one dominant eating behaviour (EB) domain score of \>2 Standard deviations of the mean will be eligible to take part.
- •People in the lifestyle only group will have eating behaviours that match all possible eating behaviour traits. Patients with type 2 diabetes can be on oral hypoglycaemic medications, including metformin, sulphonylurea, pioglitazone, an SGLT2 inhibitor. Participants can have stable obesity\-related complications.
排除标准
- •Previous bariatric surgery, being diagnosed or currently suffering from a mental health problem, being prescribed psychotropic medication that could interfere or are a contraindication for the use of any one of the three weight loss medications. Other exclusion criteria include the presence of eating disorders (previously diagnosed or currently assessed) Patients with type 1 diabetes will be excluded, and treatment with a weight loss medication or a GLP1 agonist is an exclusion criterion. Patients cannot be on insulin. Exclusions are complications that would prevent the use of weight management medication, such as recent cardiovascular events, unstable angina, coronary artery bypass grafting, ischaemic stroke, myocardial infarction, percutaneous coronary intervention, epilepsy, or psychiatric disorder.
结局指标
主要结局
未指定
相似试验
已完成
不适用
Towards a more custom tailored treatment of obesity: Subtyping the motivation to overeatobesitasobesityoverweightNL-OMON41567Alan Turing Institute Almere400
尚未招募
不适用
Towards a more custom tailored treatment of obesity: Subtyping the motivation to overeat.obesityNL-OMON21495Alan Turing Institute AlmereLouis Armstrongweg 841311RL Almere400
已完成
3 期
Individualized Obesity PharmacotherapyObesityNCT03374956Mayo Clinic193
已完成
不适用
Matched treatment of obesity in overweight patients. A randomised controlled trial. (pilot is non-randomised treatment-control study. This ABR application pertains to the pilot study)overgewichtobesity and eating disorders10014067NL-OMON31706GGZ Oost Brabant (Rosmalen)50
已完成
不适用
Tailored implementation of guidelines for obesity barriers studyISRCTN48667769niversity of Leicester (UK)350